MLN7243 (TAK-243)

MLN7243 · Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MLN7243 (TAK-243), covering 2019-03-14 to 2019-03-14. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation Study of MLN7243 (TAK-243) in Adult Participants With Advanced Solid Tumors [Phase 1]